Waverley Pharma Inc.
WAVE.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -453.40K | -359.50K | -264.60K | -291.90K | -523.80K |
| Total Depreciation and Amortization | 59.40K | 59.60K | 59.60K | 47.10K | 32.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 82.80K | 65.20K | 86.40K | 54.50K | 89.20K |
| Change in Net Operating Assets | -59.50K | -201.70K | -211.50K | -4.70K | 73.80K |
| Cash from Operations | -370.80K | -436.60K | -330.30K | -195.20K | -328.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -189.70K | -5.40K | 184.30K | 184.30K | 184.30K |
| Cash Acquisitions | 0.00 | -152.70K | -152.60K | -601.10K | -601.10K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 189.70K | 189.70K | -- | -- | -- |
| Cash from Investing | 0.00 | 31.60K | 31.70K | -416.80K | -416.80K |
| Total Debt Issued | 473.70K | 409.70K | 274.70K | 956.30K | 1.13M |
| Total Debt Repaid | -32.60K | -32.80K | -34.90K | -26.70K | -18.50K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 317.30K | 270.60K | 172.10K | 678.30K | 810.00K |
| Foreign Exchange rate Adjustments | -1.00K | -1.50K | 4.40K | 4.40K | 4.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -54.50K | -135.80K | -121.90K | 70.90K | 69.10K |